Global Reach
Connecting with Partners Worldwide
Leveraging three global strategic hubs, DIFF Biotech has established an international intellectual property footprint with more than 20 patents filed or granted across key markets, including the United States, Europe, Brazil, South Africa, Thailand, Malaysia, and other countries along the Belt and Road Initiative. Through our global presence and collaborative network, we are committed to advancing innovative biotechnology solutions and building partnerships with organizations worldwide.
Product
Next Generation Protease Inhibitor Screening System
This system is based on a co-expression mechanism using custom plasmids, Taking the novel coronavirus as an example, it combines recombinant green fluorescent protein (rGFP) with the coronavirus 3CL protease. In this system, the rGFP sequence incorporates specific cleavage sites for the 3CL protease.